Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine as Adjuvant Therapy for Children With Acute Status Asthmaticus
NCT03338205Phase 3Withdrawn
- Sponsor
- Augusta University
- Start
- Jan 2020
- Primary completion
- Dec 2021
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ketamine in status asthmaticus, sponsored by Augusta University. Planned start Jan 2020; status: withdrawn.
02
Drugs
ketamine
03
Conditions
status asthmaticus
Beyond the preview
Go deeper on NCT03338205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03338205.